Filing Details
- Accession Number:
- 0001209191-23-028813
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-11 17:04:44
- Reporting Period:
- 2023-04-28
- Accepted Time:
- 2023-05-11 17:04:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Street San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-28 | 317 | $66.88 | 426,213 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2023-05-09 | 30,000 | $67.81 | 456,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-09 | 13,626 | $94.22 | 442,587 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-09 | 14,964 | $95.49 | 427,623 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-09 | 1,410 | $95.90 | 426,213 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-05-10 | 30,000 | $67.81 | 456,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-10 | 21,453 | $94.65 | 434,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-10 | 8,547 | $95.34 | 426,213 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2023-05-09 | 30,000 | $0.00 | 30,000 | $67.81 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2023-05-09 | 30,000 | $0.00 | 30,000 | $67.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 99,130 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
| 69,130 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 247,333 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
| Common Stock | 100 | Indirect | Shares held as UTMA custodian for child |
| Common Stock | 100 | Indirect | Shares held as UTMA custodian for child |
Footnotes
- Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-1 plan executed on November 17, 2022.
- The price in column 4 is the weighted average price. The price actually received ranged from $93.85 to $94.83. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $94.86 to $95.85. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $95.86 to $95.97. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $94.12 to $95.11. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $95.115 to $95.81. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
